The most common side effects of retatrutide involve the digestive system , including: nausea vomiting diarrhea constipation These symptoms are typical for medications that influence gut hormones and appetite regulation
Management: This is generally a good sign that it's working
This injectable medication works by suppressing appetite, reducing food cravings, and promoting a feeling of fullness
To view or add a comment, sign in Retatrutide Raises the Bar in Early Type 2 Diabetes Management The TRANSCEND-T2D-1 Phase 3 trial, recently published in The Lancet, evaluated retatrutide, a novel once-weekly triple agonist (GIP/GLP-1/Glucagon receptor agonist), in adults with early type 2 diabetes managed with diet and exercise alone
[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Baker M.B., Binda D.D., Nozari A., Kennedy J.M., Dienes E., Baker W.E